Lead Product(s) : Undisclosed
Therapeutic Area : Psychiatry/Psychology
Study Phase : Discovery
Sponsor : Indivior
Deal Size : $330.0 million
Deal Type : Collaboration
Addex Receives Additional $2.8 Million from Indivior and Extends Gabab Pam Research Collaboration
Details : The collaboration covers the discovery of novel oral gamma-aminobutyric acid receptor subtype B (GABAB) positive allosteric modulator (PAM) compounds as potential therapies for multiple disease areas.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : $5.0 million
February 11, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Discovery
Sponsor : Indivior
Deal Size : $330.0 million
Deal Type : Collaboration